WO2023088394A3 - New crystal forms of lurbinectedin and preparation thereof - Google Patents
New crystal forms of lurbinectedin and preparation thereof Download PDFInfo
- Publication number
- WO2023088394A3 WO2023088394A3 PCT/CN2022/132675 CN2022132675W WO2023088394A3 WO 2023088394 A3 WO2023088394 A3 WO 2023088394A3 CN 2022132675 W CN2022132675 W CN 2022132675W WO 2023088394 A3 WO2023088394 A3 WO 2023088394A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- degrees
- lurbinectedin
- preparation
- new crystal
- crystal forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Abstract
A new crystal form C and a new crystal form D of Lurbinectedin; an XRPD spectrum of crystal form C has characteristic Bragg angles at 4.0 degrees, 7.8 degrees, 10.1 degrees, 11.9 degrees, 18.2 degrees and 25.4 degrees; and an XRPD spectrum of crystal form D has characteristic Bragg angles at 4.7 degrees, 7.9 degrees, 9.4 degrees, 11.9 degrees, 13.0 degrees, 16.8 degrees, 20.3 degrees, 24.6 degrees and 25.5 degrees.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111398172.5A CN115246846A (en) | 2021-11-19 | 2021-11-19 | New crystal form of rubitinid and preparation thereof |
CN202111398172.5 | 2021-11-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2023088394A2 WO2023088394A2 (en) | 2023-05-25 |
WO2023088394A3 true WO2023088394A3 (en) | 2023-09-21 |
Family
ID=83698861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2022/132675 WO2023088394A2 (en) | 2021-11-19 | 2022-11-17 | New crystal forms of lurbinectedin and preparation thereof |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115246846A (en) |
WO (1) | WO2023088394A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115246846A (en) * | 2021-11-19 | 2022-10-28 | 江苏慧聚药业股份有限公司 | New crystal form of rubitinid and preparation thereof |
CN115304619A (en) * | 2022-04-08 | 2022-11-08 | 上海皓元医药股份有限公司 | Crystal form of rubitinid and preparation method thereof |
CN114940682A (en) * | 2022-05-18 | 2022-08-26 | 博瑞制药(苏州)有限公司 | Crystal form of ribitdine, preparation method and application thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1564822A (en) * | 2001-08-07 | 2005-01-12 | 法马马有限公司 | Antitumoral analogs |
WO2012062920A1 (en) * | 2010-11-12 | 2012-05-18 | Pharma Mar, S.A. | Combination therapy with an antitumor alkaloid |
WO2021099635A1 (en) * | 2019-11-21 | 2021-05-27 | Pharma Mar, S.A. | New solid state form of lurbinectedin |
CN115246846A (en) * | 2021-11-19 | 2022-10-28 | 江苏慧聚药业股份有限公司 | New crystal form of rubitinid and preparation thereof |
-
2021
- 2021-11-19 CN CN202111398172.5A patent/CN115246846A/en active Pending
-
2022
- 2022-11-17 WO PCT/CN2022/132675 patent/WO2023088394A2/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1564822A (en) * | 2001-08-07 | 2005-01-12 | 法马马有限公司 | Antitumoral analogs |
WO2012062920A1 (en) * | 2010-11-12 | 2012-05-18 | Pharma Mar, S.A. | Combination therapy with an antitumor alkaloid |
WO2021099635A1 (en) * | 2019-11-21 | 2021-05-27 | Pharma Mar, S.A. | New solid state form of lurbinectedin |
CN115246846A (en) * | 2021-11-19 | 2022-10-28 | 江苏慧聚药业股份有限公司 | New crystal form of rubitinid and preparation thereof |
Non-Patent Citations (1)
Title |
---|
WEIMING HE; ZHIGAO ZHANG; DAWEI MA: "A Scalable Total Synthesis of the Antitumor Agents Et‐743 and Lurbinectedin", ANGEWANDTE CHEMIE INTERNATIONAL EDITION, VERLAG CHEMIE, HOBOKEN, USA, vol. 58, no. 12, 14 February 2019 (2019-02-14), Hoboken, USA, pages 3972 - 3975, XP072095926, ISSN: 1433-7851, DOI: 10.1002/anie.201900035 * |
Also Published As
Publication number | Publication date |
---|---|
CN115246846A (en) | 2022-10-28 |
WO2023088394A2 (en) | 2023-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2023088394A3 (en) | New crystal forms of lurbinectedin and preparation thereof | |
USD866536S1 (en) | Antenna | |
USD875721S1 (en) | Antenna | |
USD909352S1 (en) | Antenna | |
USD909353S1 (en) | Antenna | |
USD896795S1 (en) | Antenna | |
USD874448S1 (en) | Antenna | |
USD895587S1 (en) | Antenna | |
USD907015S1 (en) | Antenna | |
CA3155889A1 (en) | Hydrophobic polyimide aerogels | |
AU2020330570A8 (en) | Process of making CFTR modulators | |
USD954691S1 (en) | Antenna | |
WO2019178191A8 (en) | O-glycoprotein-2-acetamido-2-deoxy-3-d-glycopyranosidase inhibitors | |
ZA202207729B (en) | Solid state form of pyroxasulfone | |
EP3840756A4 (en) | Improved synthesis of 1,4-diazaspiro[5.5]undecan-3-one | |
EP3887368A4 (en) | 3/4-((2e,6e)-3,7,11-trimethyldodeca-2,6,10-trienylthio)benzamide derivative compounds | |
WO2005092310A3 (en) | Chemically stable compositions of 4-hydroxy tamoxifen | |
USD858491S1 (en) | Antenna | |
EP3774787A4 (en) | A compound, a reaction product of said compound and production methods thereof | |
USD944780S1 (en) | Antenna | |
USD895586S1 (en) | Antenna | |
WO2019078653A3 (en) | Modified conjugated diene-based polymer and method for preparing same | |
EP3971181A4 (en) | 3-aryloxyl-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof | |
WO2020210174A3 (en) | Sulfonyldiazoles and n-(fluorosulfonyl)azoles, and methods of making the same | |
USD819609S1 (en) | Antenna inlay |